Abstract
Introduction
Omega-3 possesses anti-inflammatory and lipid metabolism modifying effects in rheumatoid arthritis (RA), but inconsistency exists among previous studies. This meta-analysis intended to explore the effects of omega-3 supplementation on fatty acid distribution, blood lipid profiles, inflammation, and disease activity in RA patients.
Methods
This meta-analysis followed the Preferred Reporting Item for Systematic Reviews and Meta-Analyses (PRISMA) protocol. PubMed, Web of Science, and Embase databases were searched until August 31, 2023.
Results
Eighteen randomized controlled trials with 1018 RA patients were included. Regarding fatty acid distribution, omega-3 supplementation increased eicosapentaenoic acid (EPA) [standardized mean difference (SMD): 0.74; 95% confidence interval (CI): 0.46, 1.01; P < 0.001] and docosahexanoic acid (DHA) (SMD: 0.62; 95% CI: 0.35, 0.89; P < 0.001), but reduced omega-6:omega-3 ratio (SMD: -1.06; 95% CI: -1.39, -0.73; P < 0.001) in RA patients. Regarding blood lipid, omega-3 supplementation decreased triglyceride (TG) in RA patients (SMD: -0.47; 95% CI: -0.78, -0.16; P = 0.003). Regarding clinical symptoms, omega-3 supplementation reduced tender joint count (TJC) in RA patients (SMD: -0.59; 95% CI: -0.79, -0.39; P < 0.001). Notably, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and disease activity score on 28 joints (DAS28) score were slightly decreased by omega-3 supplementation but without statistical significance (all P > 0.05). Publication bias was low, and stability assessed by sensitivity analysis was good.
Conclusion
Omega-3 supplementation increases EPA and DHA, but reduces the omega-6:omega-3 ratio, TG, and TJC in RA patients.
Key Points • Omega-3 increased EPA and DHA, but decreased omega-6:omega-3 ratio in RA patients. • Omega-3 reduced TG and TJC in RA patients. • Omega-3 showed limited effects on CRP, ESR, and DAS28 scores in RA patients. |
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10067-024-07040-0/MediaObjects/10067_2024_7040_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10067-024-07040-0/MediaObjects/10067_2024_7040_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10067-024-07040-0/MediaObjects/10067_2024_7040_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10067-024-07040-0/MediaObjects/10067_2024_7040_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10067-024-07040-0/MediaObjects/10067_2024_7040_Fig5_HTML.png)
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Almutairi K, Nossent J, Preen D et al (2021) The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 41(5):863–877. https://doi.org/10.1007/s00296-020-04731-0
Fraenkel L, Bathon JM, England BR et al (2021) 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73(7):1108–1123. https://doi.org/10.1002/art.41752
Mankia K, Di Matteo A, Emery P (2020) Prevention and cure: The major unmet needs in the management of rheumatoid arthritis. J Autoimmun 110:102399. https://doi.org/10.1016/j.jaut.2019.102399
Michaud K, Pope J, van de Laar M et al (2021) Systematic literature review of residual symptoms and an unmet need in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 73(11):1606–1616. https://doi.org/10.1002/acr.24369
Dijkshoorn B, Raadsen R, Nurmohamed MT (2022) Cardiovascular disease risk in rheumatoid arthritis anno 2022. J Clin Med 11(10). https://doi.org/10.3390/jcm11102704
Figus FA, Piga M, Azzolin I et al (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776. https://doi.org/10.1016/j.autrev.2021.102776
Logstrup BB, Ellingsen T, Pedersen AB et al (2021) Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population. Rheumatology (Oxford) 60(3):1400–1409. https://doi.org/10.1093/rheumatology/keaa374
Popescu D, Rezus E, Badescu MC et al (2023) Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy. Life (Basel) 13(2). https://doi.org/10.3390/life13020319
Raad T, Griffin A, George ES et al (2021) Dietary interventions with or without omega-3 supplementation for the management of rheumatoid arthritis: a systematic review. Nutrients 13(10). https://doi.org/10.3390/nu13103506
Pan M, Zhao F, **e B et al (2021) Dietary omega-3 polyunsaturated fatty acids are protective for myopia. Proc Natl Acad Sci U S A 118(43). https://doi.org/10.1073/pnas.2104689118
Ruscica M, Sirtori CR, Carugo S et al (2022) Omega-3 and cardiovascular prevention - Is this still a choice? Pharmacol Res 182:106342. https://doi.org/10.1016/j.phrs.2022.106342
Cleland LG, French JK, Betts WH et al (1988) Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 15(10):1471–1475
Park Y, Lee A, Shim SC et al (2013) Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. J Nutr Biochem 24(7):1367–1372. https://doi.org/10.1016/j.jnutbio.2012.11.004
Das Gupta AB, Hossain AK, Islam MH et al (2009) Role of omega-3 fatty acid supplementation with indomethacin in suppression of disease activity in rheumatoid arthritis. Bangladesh Med Res Counc Bull 35(2):63–68. https://doi.org/10.3329/bmrcb.v35i2.3020
Dawczynski C, Schubert R, Hein G et al (2009) Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Br J Nutr 101(10):1517–1526. https://doi.org/10.1017/S0007114508076216
Gioxari A, Kaliora AC, Marantidou F et al (2018) Intake of omega-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a systematic review and meta-analysis. Nutrition 45(114–124):e114. https://doi.org/10.1016/j.nut.2017.06.023
Veselinovic M, Vasiljevic D, Vucic V et al (2017) Clinical benefits of n-3 PUFA and ɤ-Linolenic acid in patients with rheumatoid arthritis. Nutrients 9(4). https://doi.org/10.3390/nu9040325
Dawczynski C, Dittrich M, Neumann T et al (2018) Docosahexaenoic acid in the treatment of rheumatoid arthritis: A double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil. Clin Nutr 37(2):494–504. https://doi.org/10.1016/j.clnu.2017.02.021
Lindqvist HM, Gjertsson I, Andersson S et al (2019) Influence of blue mussel (Mytilus edulis) intake on fatty acid composition in erythrocytes and plasma phospholipids and serum metabolites in women with rheumatoid arthritis. Prostaglandins Leukot Essent Fatty Acids 150:7–15. https://doi.org/10.1016/j.plefa.2019.08.004
Ghaseminasab-Parizi M, Nazarinia MA, Akhlaghi M (2022) The effect of flaxseed with or without anti-inflammatory diet in patients with rheumatoid arthritis, a randomized controlled trial. Eur J Nutr 61(3):1377–1389. https://doi.org/10.1007/s00394-021-02707-9
Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928
Luo D, Wan X, Liu J et al (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27(6):1785–1805. https://doi.org/10.1177/0962280216669183
Wan X, Wang W, Liu J et al (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135
Berbert AA, Kondo CR, Almendra CL et al (2005) Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 21(2):131–136. https://doi.org/10.1016/j.nut.2004.03.023
Kremer JM, Bigauoette J, Michalek AV et al (1985) Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1(8422):184–187. https://doi.org/10.1016/s0140-6736(85)92024-0
Tulleken JE, Limburg PC, Muskiet FA et al (1990) Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis. Arthritis Rheum 33(9):1416–1419. https://doi.org/10.1002/art.1780330914
Nielsen GL, Faarvang KL, Thomsen BS et al (1992) The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest 22(10):687–691. https://doi.org/10.1111/j.1365-2362.1992.tb01431.x
van der Tempel H, Tulleken JE, Limburg PC et al (1990) Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 49(2):76–80. https://doi.org/10.1136/ard.49.2.76
Sundrarjun T, Komindr S, Archararit N et al (2004) Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J Int Med Res 32(5):443–454. https://doi.org/10.1177/147323000403200501
Nordstrom DC, Honkanen VE, Nasu Y et al (1995) Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed. Rheumatol Int 14(6):231–234. https://doi.org/10.1007/BF00262088
Galarraga B, Ho M, Youssef HM et al (2008) Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford) 47(5):665–669. https://doi.org/10.1093/rheumatology/ken024
Kolahi S, Ghorbanihaghjo A, Alizadeh S et al (2010) Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clin Biochem 43(6):576–580. https://doi.org/10.1016/j.clinbiochem.2009.12.011
Ghorbanihaghjo A, Kolahi S, Seifirad S et al (2012) Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: a double-blind randomized controlled trial. Arch Iran Med 15(9):549–552
Nikiphorou E, Philippou E (2023) Nutrition and its role in prevention and management of rheumatoid arthritis. Autoimmun Rev 22(7):103333. https://doi.org/10.1016/j.autrev.2023.103333
Lane K, Derbyshire E, Li W et al (2014) Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Crit Rev Food Sci Nutr 54(5):572–579. https://doi.org/10.1080/10408398.2011.596292
Shahidi F, Ambigaipalan P (2018) Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits. Annu Rev Food Sci Technol 9:345–381. https://doi.org/10.1146/annurev-food-111317-095850
Tvrzicka E, Kremmyda LS, Stankova B et al (2011) Fatty acids as biocompounds: their role in human metabolism, health and disease–a review. Part 1: classification, dietary sources and biological functions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155(2):117–130. https://doi.org/10.5507/bp.2011.038
Hansildaar R, Vedder D, Baniaamam M et al (2021) Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol 3(1):e58–e70. https://doi.org/10.1016/S2665-9913(20)30221-6
Oscarsson J, Hurt-Camejo E (2017) Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. Lipids Health Dis 16(1):149. https://doi.org/10.1186/s12944-017-0541-3
Soni N, Ross AB, Scheers N et al (2019) The Omega-3 fatty acids EPA and DHA, as a part of a murine High-Fat diet, reduced lipid accumulation in brown and white adipose tissues. Int J Mol Sci 20(23). https://doi.org/10.3390/ijms20235895
Yuan M, Zhang Y, Hua T et al (2021) Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trial. Clin Nutr 40(2):445–459. https://doi.org/10.1016/j.clnu.2020.05.034
Tanaka N, Zhang X, Sugiyama E et al (2010) Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol 80(10):1601–1612. https://doi.org/10.1016/j.bcp.2010.07.031
Kang JX, Weylandt KH (2008) Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 49:133–143. https://doi.org/10.1007/978-1-4020-8831-5_5
Calder PC (2017) Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans 45(5):1105–1115. https://doi.org/10.1042/BST20160474
Lee YH, Bae SC, Song GG (2012) Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res 43(5):356–362. https://doi.org/10.1016/j.arcmed.2012.06.011
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
Conceptualization, Wen Wang and Yinshan Zang; Methodology, Yinshan Zang; Formal Analysis, Wen Wang and Yinshan Zang; Investigation, Yan Xu and Jun Zhou; Resources, Yan Xu and Jun Zhou.; Data Curation, Wen Wang, Yan Xu and Jun Zhou; Writing – Original Draft Preparation, All authors; Writing – Review & Editing, All authors; Supervision, Yinshan Zang; Project Administration, Wen Wang;
Corresponding author
Ethics declarations
Conflicts of interest
The authors have declared no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, W., Xu, Y., Zhou, J. et al. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Clin Rheumatol (2024). https://doi.org/10.1007/s10067-024-07040-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10067-024-07040-0